Alexion recalls some Soliris batches

Share this article:

Pricey rare disease drug Soliris is being recalled. Manufacturer Alexion noted in an 8K that it was recalling less than 1% of its stock after tests showed visible particles in the medication. The company says replacing the drugs will cost between $10 million and $25 million, and that the recall affected only products in the US.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

AstraZeneca takes on pediatricians

The American Academy of Pediatricians says an AstraZeneca drug for preemies should be used less often, and the drugmaker is fighting back with an ad campaign that says the new guidelines put too many at risk.

UK generic use soared in 2013

Generics made up almost 75% of prescriptions in the United Kingdom last year.

GSK refutes consumer spin-off rumor

The company refutes a Financial Times rumor that one was happening soonish.